57
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Influence of treatment with alendronate on the speed of sound, an ultrasound parameter, of the calcaneus in postmenopausal Japanese women with osteoporosis: a clinical practice-based observational study

, , &
Pages 287-293 | Published online: 20 Jun 2012

References

  • BlackDMCummingsSRKarpfDBfor Fracture Intervention Trial Research GroupRandomised trial of effect of alendronate on risk of fracture in women with existing vertebral fracturesLancet19963489041153515418950879
  • CummingsSRBlackDMThompsonDEEffect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention TrialJAMA199828024207720829875874
  • WellsGACranneyAPetersonJAlendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenCochrane Database Syst Rev20081CD00115518253985
  • FujiwaraSSoneTYamazakiKHeel bone ultrasound predicts non-spine fracture in Japanese men and womenOsteoporos Int200516122107211216195817
  • WüsterCHeilmannPPereira-LimaJSchlegelJAnstättKSoballaTQuantitative ultrasonometry (QUS) for the evaluation of osteoporosis risk: reference data for various measurement sites, limitations and application possibilitiesExp Clin Endocrinol Diabetes199810642772889792459
  • GonnelliSCepollaroCMontagnaniAHeel ultrasonography in monitoring alendronate therapy: a four-year longitudinal studyOsteoporos Int200213541542112086353
  • KushidaKShirakiMNakamuraTThe efficacy of alendronate in reducing the risk for vertebral fracture in Japanese patients with osteoporosis: a randomized, double-blind, active-controlled, double-dummy trialCurr Ther Res Clin Exp2002639606620
  • KushidaKShirakiMNakamuraTAlendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis: a 3-year follow-up studyJ Bone Miner Metab200422546246815316867
  • ShirakiMKushidaKFukunagaMfor Alendronate Phase III Osteoporosis Treatment Research GroupA double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosisOsteoporos Int199910318319210525709
  • UchidaSTaniguchiTShimizuTTherapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized studyJ Bone Miner Metab200523538238816133688
  • OrimoHSugiokaYFukunagaMDiagnostic criteria of primary osteoporosisJ Bone Miner Metab1998163139150
  • OrimoHHayashiYFukunagaMfor Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone and Mineral ResearchDiagnostic criteria for primary osteoporosis: year 2000 revisionJ Bone Miner Metab200119633133711685647
  • ItoMNishidaAKonoJKonoMUetaniMHayashiKWhich bone densitometry and which skeletal site are clinically useful for monitoring bone mass?Osteoporos Int2003141295996412955312
  • YamaguchiTYamamotoMKanazawaIQuantitative ultrasound and vertebral fractures in patients with type 2 diabetesJ Bone Miner Metab201129562663221437613
  • NishizawaYNakamuraTOhtaHfor Committee on the Guidelines for the Use of Biochemical Markers of Bone Turnover in Osteoporosis, Japan Osteoporosis SocietyGuidelines for the use of biochemical markers of bone turnover in osteoporosis (2004)J Bone Miner Metab20052329710415750686
  • KhoslaSBurrDCauleyJfor American Society for Bone and Mineral ResearchBisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral ResearchJ Bone Miner Res200722101479149117663640
  • ShaneEBurrDEbelingPRfor American Society for Bone and Mineral ResearchAtypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral ResearchJ Bone Miner Res201025112267229420842676
  • PazianasMCompstonJHuangCLAtrial fibrillation and bisphosphonate therapyJ Bone Miner Res201025121020091928
  • IwamotoJTakedaTSatoYUzawaMEarly changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosisJ Bone Miner Metab200523323824215838627
  • IwamotoJMiyataASatoYTakedaTMatsumotoHFive-year alendronate treatment outcome in older postmenopausal Japanese women with osteoporosis or osteopenia and clinical risk factors for fracturesTher Clin Risk Manag2009577377919851524
  • IwamotoJSatoYUzawaMTakedaTMatsumotoHSeven years’ experience with alendronate in postmenopausal Japanese women with osteoporosisTher Clin Risk Manag2010620120620463781
  • IwamotoJTakedaTSatoYUzawaMEffects of alendronate on metacarpal and lumbar bone mineral density, bone resorption, and chronic back pain in postmenopausal women with osteoporosisClin Rheumatol200423538338915278749
  • IwamotoJTakedaTSatoYUzawaMComparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosisClin Rheumatol200726216116716565894
  • KishimotoHYohKOhtaHReference and cut-off value of quantitative ultrasound measured using CM-100Osteoporos Jpn200311307310 Japanese
  • YamaguchiJTrumanGCameronIDLifestyle factors affecting bone ultrasonometry of the calcaneus in Japanese womenCalcif Tissue Int2000661434610602843
  • KitagawaJNakaharaYAssociations of daily walking steps with calcaneal ultrasound parameters and a bone resorption marker in elderly Japanese womenJ Physiol Anthropol200827629530019057118
  • IkedaYIkiMPrecision control and seasonal variations in quantitative ultrasound measurement of the calcaneusJ Bone Miner Metab200422658859315490269
  • KajiHHisaIInoueYNaitoJSugimotoTKasugaMAnalysis of factors affecting increase in bone mineral density at lumbar spine by bisphosphonate treatment in postmenopausal osteoporosisJ Bone Miner Metab2009271768219018454